Since 1980, Gerbsman Partners had focused on maximizing enterprise value for stakeholders and shareholders in highly leveraged, under-performing, under-capitalized and under-valued companies and their Intellectual Property. These companies typically have venture capital, private equity and/or venture lending funding.

Gerbsman Partners has also assisted numerous emerging growth and middle market companies develop and execute their financial and capital formation strategies, access the capital markets and provide for technology, digital marketing, social commerce, life science and medical device strategic alliances and licensing of Intellectual Property.

Gerbsman Partners has also participated as an Angel Investor in digital marketing, social commerce and internet technologies companies and seeks to invest in one to two new companies per year.

Since 2001, Gerbsman Partners has been involved in maximizing enterprise value for 69 technology, life science and medical device companies, through its proprietary "Date Certain M&A Process" and has restructured/terminated over $ 800 million of prohibitive real estate and equipment leases, sub-debt and creditor issues. To date, Gerbsman Partners has been involved in over $ 2.3 billion of restructurings, M&A and financing transactions.

Gerbsman Partners has offices and strategic alliances in Boston, New York, Washington, DC, Alexandria, VA, San Francisco, Orange County, Europe and Israel.